20
Participants
Start Date
July 31, 2016
Primary Completion Date
August 31, 2018
Study Completion Date
February 28, 2019
Administration of drug (Interferon-gamma 1-b) subcutaneously
SD = group who has received a single dose of IFN-gamma (10, 25, 50, and 100 mcg/m2) given once with subsequent analysis of effects (serum IL-10, Neuropterin, and IFN levels as well as neutrophil Nox2 activity and gene expression by Affimetrics Chip analysis). One month is allowed between doses. SS = administration of four doses (50 mcg/m2) of IFN-gamma given on Monday, Wednesday Friday schedule with neutrophil or monocyte function studies performed before the first and after the fourth dose to determine steady state effects.
University of Colorado Denver, Anschutz Medical Campus, Aurora
University of Colorado, Denver
OTHER